Cargando…
Editorial: Mechanisms, markers and therapeutics of synaptic pathology in Alzheimer's disease
Autores principales: | Metaxas, Athanasios, Finsen, Bente |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583522/ https://www.ncbi.nlm.nih.gov/pubmed/36278006 http://dx.doi.org/10.3389/fnins.2022.1022447 |
Ejemplares similares
-
Increased Inflammation and Unchanged Density of Synaptic Vesicle Glycoprotein 2A (SV2A) in the Postmortem Frontal Cortex of Alzheimer’s Disease Patients
por: Metaxas, Athanasios, et al.
Publicado: (2019) -
An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model
por: Kempf, Stefan J., et al.
Publicado: (2016) -
Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease
por: Metaxas, Athanasios, et al.
Publicado: (2019) -
Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer’s-like disease in mice
por: von Linstow, Christian Ulrich, et al.
Publicado: (2017) -
Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer’s disease
por: Metaxas, Athanasios, et al.
Publicado: (2019)